genova diagnostics customer service number

We will share and leverage the knowledge we gain. Our culture of learning facilitates continuous personal growth, team development, and process improvement.

Our learning organization will continuously improve our knowledge of our patients, providers, colleagues and science.

Through our actions and communication, we will continuously improve how the world perceives us. Genova Diagnostics will be valued for our unique and effective solutions. Our leadership in bringing insights to the complexity of health will be recognized by the global healthcare community. To develop new products and services, we will continually improve upon resource discipline and development processes. Our products will address a complex health problem and simplify the decision on the most effective course of action. Our products and services will provide compelling value across the primary care continuum through the best elements of laboratory science, systems biology, and clinical data synthesis. To foster this growth, we will challenge ourselves to innovate. We will continually innovate how we acquire customers, technologies, systems and companies. We will continue to invest in expanding the community of providers, patients and colleagues that benefit from our products and services. Our growth is at the core of Genova's history. The Genova Diagnostics team will improve the lives and well-being of individuals by bringing insights to the complexity of health. The internationally renowned lab is committed to the highest standards and has a team of medical experts who provide consultation to healthcare professionals, as well as a robust array of educational resources, ensuring that physicians order the right tests for their patients. Easy-to-read color graphic reports synthesize test results into actionable information and facilitate physician-patient communication. The Genova Diagnostics team promises to be the best provider of comprehensive and innovative clinical laboratory services for the prevention, diagnosis, and treatment of complex chronic disease.Ĭhronic diseases are often complex and Genova's system-based testing helps physicians develop targeted treatments for their patients. Our dedication to innovation continues to lead us to investigate a variety of new areas to expand our testing base, and providing a comprehensive diagnostic menu from which to serve your patients. Acquisitions, partnerships, and new launches are also contributing to the market's growth in North America.Headquartered in Asheville, N.C., Genova Diagnostics is a global clinical laboratory, pioneering a systems approach that supports healthcare providers in the personalized treatment and prevention of chronic disease. North America is expected to dominate the clinical laboratory services market due to the presence of key players, government organizations creating awareness, and the high burden of target and chronic diseases in the region. The segment is experiencing consolidation as players focus on strategic partnerships and collaborations. In highly populated and developing countries like India and China, independent laboratories have a significant opportunity to fill the gap of clinical service providers, leading to an increase in the number of such laboratories. The report highlights that the independent and reference laboratories segment is expected to register healthy growth over the forecast period. However, the clinical laboratory services market may face challenges due to stringent regulatory issues in various countries and a lack of skilled laborers. The increasing awareness about early disease diagnosis and the launch of technologically advanced products are also contributing to the market's growth. The demand for clinical diagnostic tests is increasing due to the rising burden of diseases like cancer and tuberculosis. The market is driven by the rising incidence of chronic and infectious diseases, increasing demand for accurate and early disease diagnosis techniques, and the growing burden of cancer. Many companies, such as Thermo Fisher Scientific, launched new products to enhance COVID-19 testing capacity. During the pandemic, there was an increase in demand for clinical diagnostics and testing technology, including molecular and serological testing for severe COVID-19 infections, leading to an overall increase in demand for clinical laboratory services.

The COVID-19 pandemic has had a positive impact on the clinical laboratory services market. COVID-19 Impact on the Clinical Laboratory Services Market The clinical laboratory services market is projected to grow from USD 261.01 billion in 2023 to USD 357.44 billion by 2028, at a CAGR of 6.49% during the forecast period (2023-2028). Global Clinical Laboratory Services Market 2023-2028: Featuring Key Players Fresenius Medical Care, Genova Diagnostics, Sonic Healthcare & More

Genova diagnostics customer service number